共 50 条
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
被引:29
|作者:
Emadi, Ashkan
[1
,2
,3
]
Chua, Joel V.
[2
,4
]
Talwani, Rohit
[2
,4
]
Bentzen, Soren M.
[1
,5
]
Baddley, John
[1
,2
,4
]
机构:
[1] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, 22 South Greene St,Room N9E06, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA
来源:
关键词:
COVID-19;
Randomised controlled trial;
protocol;
SARS-CoV;
imatinib;
tyrosine kinase inhibitor;
TKI;
lysosomal sequestration;
viral ABL-1 signalling;
TKI-induced attenuation of vascular leak;
TKI-induced prevention and treatment lung inflammation;
D O I:
10.1186/s13063-020-04819-9
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
引用
收藏
页数:5
相关论文